Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
PROFESSOR PIER FRANCESCO BASSI, Catholic University of the Sacred Heart
ClinicalTrials.gov Identifier:
NCT01566292
First received: March 9, 2012
Last updated: March 27, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Publications: